Qure.ai and Therapixel are partnering to improve access to breast cancer detection through artificial intelligence (AI).
Through the partnership, Qure.ai will be a global distributor for Therapixel's MammoScreen, an AI-powered decision support tool for breast cancer screening. The companies said they aim to improve the accuracy and efficiency of breast cancer detection.